sirupus plantaginis 647,5 mg/5 ml sīrups
p.p.f. hasco-lek s.a., poland - ū0aurlapu ceļctekas lapu šķidrais ekstrakts - sīrups - 647,5 mg/5 ml
mucofalk orange 3,25 g/5 g granulas
dr. falk pharma gmbh, germany - olveida ceļctekas sēklsedze - granulas - 3,25 g/5 g
qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - kuņģa-zarnu trakta stromas audzēji - antineoplastiski līdzekļi - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiski līdzekļi - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
stoptussin fyto sīrups
teva czech industries s.r.o., czech republic - thymi iegūt šķidrums, serpylli iegūt šķidrums, ceļmallapu ekstrakts šķidruma - sīrups
erlotinib zentiva 150 mg apvalkotās tabletes
zentiva, k.s., czech republic - erlotinibs - apvalkotā tablete - 150 mg
erlotinib krka 25 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - erlotinibs - apvalkotā tablete - 25 mg
erlotinib krka 100 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - erlotinibs - apvalkotā tablete - 100 mg
erlotinib krka 150 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - erlotinibs - apvalkotā tablete - 150 mg
iressa
astrazeneca ab - gefitinib - karcinoma, nesīkšūnu plaušas - antineoplastiski līdzekļi - iressa ir norādīts ārstēšanai pieaugušiem pacientiem ar lokāli papildu vai metastātiska nav maza šūnu plaušu vēzis ar aktivizējot mutācijas epidermas augšanas faktora receptoru tirozīns kinase.